
Universe Pharmaceuticals Inc: updates and filings
Price
$1.52
November 18, 2026
What Ploutos Investor adds for Universe Pharmaceuticals
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from FY2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
- A figure that did not match the numbers it is built from has been left out.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 9, 2026FilingFormEFFECT
- Oct 6, 2026Current report (foreign company)Form6-K
- Sep 29, 2026REGISTRATION STATEMENTFormF-3
- Sep 3, 2026Current report (foreign company) (amendment)Form6-K/A
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 1, 2026Current report (foreign company)Form6-K
- Jul 31, 2026Current report (foreign company)Form6-K
- Jul 29, 2026Current report (foreign company)Form6-K
- Jun 26, 2026Current report (foreign company)Form6-K
- May 21, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- May 14, 2026Current report (foreign company)Form6-K
- Apr 16, 2026Current report (foreign company)Form6-K
- Feb 11, 2026Current report (foreign company)Form6-K
- Jan 29, 2026Annual report (foreign company)for the period to Sep 30, 2025Form20-F
- Jan 7, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 3, 2025Current report (foreign company)Form6-K
- Aug 26, 2025Current report (foreign company)Form6-K
- Jul 29, 2025Current report (foreign company)Form6-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 9, 2026 | EFFECT | Filing | Document |
| Oct 6, 2026 | 6-K | Current report (foreign company) | Document |
| Sep 29, 2026 | F-3 | REGISTRATION STATEMENT | Document |
| Sep 3, 2026 | 6-K/A | Current report (foreign company) (amendment) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 1, 2026 | 6-K | Current report (foreign company) | Document |
| Jul 31, 2026 | 6-K | Current report (foreign company) | Document |
| Jul 29, 2026 | 6-K | Current report (foreign company) | Document |
| Jun 26, 2026 | 6-K | Current report (foreign company) | Document |
| May 21, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| May 14, 2026 | 6-K | Current report (foreign company) | Document |
| Apr 16, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 11, 2026 | 6-K | Current report (foreign company) | Document |
| Jan 29, 2026 | 20-F | Annual report (foreign company)for the period to Sep 30, 2025 | Document |
| Jan 7, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 3, 2025 | 6-K | Current report (foreign company) | Document |
| Aug 26, 2025 | 6-K | Current report (foreign company) | Document |
| Jul 29, 2025 | 6-K | Current report (foreign company) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 24, 2020.
The full analysis
What do Universe Pharmaceuticals's filings show?
The filings are where every one of Universe Pharmaceuticals's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.